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months after surgery. RESULTS: A total of 5311 patients were part of the study
cohort (85.1% female, age at surgery 38.5  10.1 years, 61.9% with at least one
obesity-related co-morbidity). At 12-months, data from 1,035 patients were avail-
able, with 96.1% of patients scoring good or better at BAROS. Adherence to fol-
low-up visits was not significantly associated with BAROS at 1 year (coefficient
-0.046, 95%CI -0.218 to 0.126). At 24-months, data from 319 patients were available,
with 92.2% scoring good or better at BAROS. Adherence to follow-up visits was
significantly associated with a better BAROS score (coefficient 1.66, 95%CI 1.13-
2.18). Inmultivariate linear regression, presence of co-morbidity is associated with
higher BAROS scores at 24months (p0.001), and adherence to follow-up visits acts
as an effectmodifier of this association, with a positive effect in the sub-groupwith
co-morbidity. CONCLUSIONS: Patients with obesity related co-morbidity seems to
benefitmore fromRYGB at 24months post-surgery. Adherence tomedical appoint-
ments is an important variable to drive better outcomes in this population.
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OBJECTIVES: While radiographic fusion and pain are commonly-reported out-
comes in clinical studies of spinal fusion for degenerative disc disease (DDD), pa-
tient functioning is often the main goal of treatment. Given the increasing empha-
sis on patient-centered outcomes in comparative effectiveness research, we
sought to examine the frequency and trends in reporting of functional outcomes in
spinal fusion studies.METHODS:A search of PubMed and Cochrane from July 2011,
1975was conducted. Inclusion criteria included: English, abstract available, human
subjects, 1 arm with lumbar fusion, pain/functional outcomes reported, mini-
mum two years follow-up, adults with DDD including: spondylosis, spondylolis-
thesis, stenosis, disc herniation, degenerative scoliosis, standalone DDD, or disco-
genic back pain, all with mention of degeneration. Functional outcomes included
the Oswestry Disability Index (ODI), SF36 Physical Component (PCS), and SF36
Physical Functioning (PF) Subscale. Results were stratified by study type (random-
ized control trial [RCT] vs. non-RCT) and publication year (2007-2011 versus before
2007). RESULTS: Out of 1526 titles and abstracts reviewed, 64 studies met study
inclusion criteria with a median sample size of 51 and median age of 55. Thirty-
seven (58%) of these were published between 2007 and 2011, with only 16 (25%)
being RCTs. ODI was the most commonly reported patient centered outcome
(N48, 75% of studies), while SF36 scores were less commonly reported (n11, 17%
of studies). A higher proportion of RCTs reported functional outcomes compared to
non-RCTs (ODI: 81% versus 73%; PCS or PF: 25% versus 15%). Thirteen studies (81%)
from 2007-2011 reported ODI compared to 67% (N18) of older studies.
CONCLUSIONS: In published studies of spinal fusion surgery for DDD, we found an
increasing use of functional outcomesmeasures, especially in randomized clinical
trials, over the past five years. The reporting of suchmeasures will greatly enhance
opportunities to conduct meta-analyses of clinical trial results to inform decisions
about comparative effectiveness.
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OBJECTIVES:This studywas conducted to compare the improvement of quality of life
in patients treated with either bariatric surgery or conventional therapy in obese Ko-
rean people.METHODS: The quality of life was investigated for 53 patients who un-
derwentbariatric surgeryand25patientswhowere treatedbyconventional therapy in
7 tertiarymedical centers. Thequality of lifewasmeasured right before treatment and
after at least fivemonth of that by self-report instruments; The instruments for mea-
suring quality of lifewere EuroQol-5D (EQ-5D), Impact ofWeight onQuality of Life-Lite
Questionnaire (IWQOL-Lite), and Obesity-related Problem scale (OP-scale). Through
themedical chart review, percent weight change from baselinewas investigated. The
differenceofQOL improvement frombaselinebetween two treatmentswascompared
using the t-test. The relationship betweenweight control and QOL improvement was
also investigated. RESULTS: The improvement of QOL was 0.174 in EQ-5D index
score and 24.6 in VAS score for bariatric surgery, and 0.071 and 17.8 for conven-
tional therapy. QOL score using IWQOL-Lite and OP-scale were 33.4 and 39.3 for
bariatric surgery and 14.3 and 9.6 for conventional therapy. Measuring by obesity-
specific questionnaires (IWQOL-Lite and OP-scale), the improvement of QOL before
and after treatments was significantly higher in bariatric surgery than conven-
tional therapy, but the general questionnaires (EQ-5D 3 level and EQ-VAS) did not
show. The percent weight change from baseline had positive correlation with the
improvement of QOL. CONCLUSIONS: The improvement in quality of life was sig-
nificantly higher among bariatric surgery group compared with the conventional
therapy group, especially for the obesity specific questionnaires.
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OBJECTIVES: Cholecystectomy is one of the most common surgical interventions
performed around the world, and it consumes great healthcare resources. Though
usually effective and safe, it associates adverse events, sometimes severe, being
considered a quality indicator of the healthcare system performance. Asymptom-
atic gallstones are not considered an indication for surgery. Immunosupression
among other conditions is an exception to this rule. Clinical controversy exists in
renal transplant recipients where cholelithiasis incidence is recognized to be high
and complications of gallstones may be harmful. Our objective is to assess the
appropiate use of cholecystectomy in kidney transplant recipients with asymp-
tomatic cholelithiasis. METHODS: We performed a systematic review of the pub-
lished literature since 1997 to date, using Medline, Embase, ISI Web of Science and
Sumsearch. The search strategy included the terms: asymptomatic gallstones,
cholelithiasis, cholecystectomy, and kidney or renal transplant. Studies were se-
lected for inclusion on the basis of their population, intervention, and clinically
relevant outcomes. Studies were critically appraised with respect to methodolog-
ical quality, grade of scientific evidence, and clinically relevant outcomes.
RESULTS: From 38 potentially relevant studies, 19 articles were disregarded be-
cause of pre-transplant and other conditions. Nineteen studies were included.
Much of the research identified was of poor quality. As there was considerable
heterogeneity we considered it inappropriate to pool the data for meta-analysis.
There is little information on its optimal approach, appropriate indications, limit-
ing factors, side effects, long-term outcomes and potential advantages over
surveillance. CONCLUSIONS: Current available literature shows a low degree of
consensus regarding cholecystectomy indication in asymptomatic patients. Some
studies advocate surgery to avoid gallstones complications while others claim that
risks are the same as in general population. Uncertainty remains surrounding this
problem and research of goodmethodological quality is urgently required to define
the appropriate role of surgery.
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OBJECTIVES: Recent reductions in length of hospital stay after TKA have resulted in
an increased demand on extended care facilities (ECF) to manage TKA postoperative
care. An exponential increase inTKAprocedures is expected by 2030 anda shortage of
resources to meet the increase is projected. Determining what factors affect patients
to be discharged directly home or to rehabilitation may assist resource allocation
decisions. The objective of this studywas to identify if preoperative patient character-
istics (age, gender, comorbidities, physical function and activity) were associatedwith
discharge to an ECF versus discharge directly home after an elective TKA.METHODS:
Patients40 years old with a primary unilateral TKA, excluding those with a 2nd TKA
surgery within the year, were retrospectively extracted from a clinical orthopedic
database between Septeber 1, 2008 – November 30, 2010. Discharge location and pre-
operative comorbidities (diabetes, hypertension, obesity [bmi30 kg/m2], cancer, os-
teoporosis, chronicbackpain, insomnia, osteoporosis)wereobtainedbychart abstrac-
tion from the electronicmedical record. Using logistic regression analysis, odds ratios
were adjusted for age, gender, preoperative patient education, levels of preoperative
physical health and activity and insurance type (medicaid, medicare, private).
RESULTS: A total of 174 patients with average age 63.8 years (SD 10.2, 41-85) were
included in the study. Overall, one-third of patients (35.6%, 62) of patients were
discharged to a ECF. In adjusted ORs, the likelihood of going to a ECF postopera-
tively were 3.23 times (95% confidence interval[CI]1.27-8.16) more likely for those
age 65 years compared to those 65 years; 2.86 times (95% CI 1.11-7.37) in
patients with a diabetes and 2.99 (95% CI 1.15-7.80) times for those with a cancer
diagnosis compared to those without diabetes and cancer, respectively.
CONCLUSIONS: We identified specific patient variables that may predict postop-
erative discharge destination. Identification is paramount to avoid delays in pa-
tient discharge and to efficiently manage available resources.
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OBJECTIVES: The goal of this study was to compare the health care resource utili-
zation and costs between obese patients who received laparoscopic adjustable
gastric banding (LAGB), laparoscopic Roux-en-Y gastric bypass (lRYGB), open Roux-
en-Y gastric bypass (oRYGB), and sleeve gastrectomy (SG).METHODS:Marketscan
claims data (2005 to 2010) were analyzed for patients 18 years old, who received
LAGB, lRYGB, oRYGB, or SG (identified using ICD-9-CM and CPT codes) and re-
mained continuously insured for12months following first date of surgery (index
date). Patients with ambiguous bariatric procedure coding or stomach or intestinal
cancer codes were excluded. RESULTS: A total of 52,359 claims met inclusion cri-
teria: LAGB (n21,075), lRYGB (n26,206), oRYGB (n4,497), and SG (n581), aver-
aging 44 to 46 years old and about 80% female. 35.5% LAGB had type II diabetes
codes compared to lRYGB (40.6%), oRYGB (42.3%), and SG (40.8%). 10.0% of the LAGB
patients were hospitalized within 12 months post-index date compared to lRYGB
(17.4%), oRYGB (20.5%), and SG (13.8%). LOS were 4.9, 6.0, 9.3, and 10.0 days; total
costs were $21,242 vs. $22,988; $31,603; and $35,631; respectively. In the diabetic
subgroup, 12.1% LAGB, 19.2% lRYGB, 23.9% oRYGB, and 17.3% SG were hospitalized
within 12 months. LOS were 5.4, 6.4, 10.4, and 11.3 days; total costs were $22,840;
$24,816; $37,698; and $35,128; respectively. Similarly, out of those with 36-month
follow-up data, 29.0% (1162/4012) LAGB patients were hospitalized compared to
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